+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 76 Pages
  • May 2024
  • GlobalData
  • IQVIA
  • ID: 4372831
IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

IQVIA Holdings Inc (IQVIA) provides information, novel technological solutions and clinical research services. The company harnesses data and science to offer an array of solutions to healthcare companies, which include clinical development, commercialization and technologies that result in significant healthcare outcomes. Its IQVIA CORE is a customized solution that provides actionable insights through big data, transformative technology and analytics with wide industry knowledge in diseases, regions, human behavior and scientific advances. IQVIA serves medical device, biotech and pharmaceutical companies; government agencies, medical researchers, patient associations, payers and investigators, among others. The company has operations in Asia, Europe, the Americas, and Africa. IQVIA is headquartered in Durham, North Carolina, the US.

IQVIA Holdings Inc Key Recent Developments

  • May 02, 2024: IQVIA Reports First-Quarter 2024 Results
  • Feb 14, 2024: IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
  • Jan 24, 2024: IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024
  • Nov 21, 2023: IQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx Conference on November 29, 2023

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • IQVIA Holdings Inc - Key Facts
  • IQVIA Holdings Inc - Key Employees
  • IQVIA Holdings Inc - Key Employee Biographies
  • IQVIA Holdings Inc - Major Products and Services
  • IQVIA Holdings Inc - History
  • IQVIA Holdings Inc - Company Statement
  • IQVIA Holdings Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • IQVIA Holdings Inc - Business Description
  • Business Segment: Contract Sales & Medical Solutions
  • Overview
  • Performance
  • Business Segment: Research & Development Solutions
  • Overview
  • Performance
  • Business Segment: Technology & Analytics Solutions
  • Overview
  • Performance
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: Asia-Pacific
  • Performance
  • Geographical Segment: Europe and Africa
  • Performance
  • IQVIA Holdings Inc - Corporate Strategy
  • IQVIA Holdings Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • IQVIA Holdings Inc - Strengths
  • IQVIA Holdings Inc - Weaknesses
  • IQVIA Holdings Inc - Opportunities
  • IQVIA Holdings Inc - Threats
  • IQVIA Holdings Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • IQVIA Holdings Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 02, 2024: IQVIA Reports First-Quarter 2024 Results
  • Feb 14, 2024: IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
  • Jan 24, 2024: IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024
  • Nov 21, 2023: IQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx Conference on November 29, 2023
  • Nov 14, 2023: IQVIA Announces Offering of Senior Secured Notes
  • Nov 01, 2023: IQVIA Reports Third-Quarter 2023 Results
  • Oct 05, 2023: Patient Organizations Gave $22 Billion in Grants for Research, Patient Services, and Access to Care Over the Last 5 Years, Says IQVIA Institute for Human Data Science
  • Oct 02, 2023: IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance
  • Sep 05, 2023: IQVIA CFO Ron Bruehlman to Speak at Baird Global Healthcare Conference on September 13, 2023
  • Jun 27, 2023: IQVIA Wins Prestigious “Best AI-Based Solution for Healthcare” Award in 2023 Artificial Intelligence Breakthrough Awards
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • IQVIA Holdings Inc, Key Facts
  • IQVIA Holdings Inc, Key Employees
  • IQVIA Holdings Inc, Key Employee Biographies
  • IQVIA Holdings Inc, Major Products and Services
  • IQVIA Holdings Inc, History
  • IQVIA Holdings Inc, Other Locations
  • IQVIA Holdings Inc, Subsidiaries
  • IQVIA Holdings Inc, Key Competitors
  • IQVIA Holdings Inc, Ratios based on current share price
  • IQVIA Holdings Inc, Annual Ratios
  • IQVIA Holdings Inc, Annual Ratios (Cont...1)
  • IQVIA Holdings Inc, Annual Ratios (Cont...2)
  • IQVIA Holdings Inc, Interim Ratios
  • IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • IQVIA Holdings Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • IQVIA Holdings Inc, Performance Chart (2019 - 2023)
  • IQVIA Holdings Inc, Ratio Charts
  • IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ZS Associates Inc
  • RTI Health Solutions
  • Panalgo LLC
  • Medidata Solutions Inc
  • Pharmaceutical Product Development LLC
  • Clarivate Plc
  • Press Ganey Associates Inc
  • ICON Plc
  • Fortrea Inc
  • Definitive Healthcare Corp
  • CompuGroup Medical SE & Co KGaA
  • UDG Healthcare Plc
  • McKinsey & Co Inc
  • Infosys Ltd
  • Cerner
  • Aetion Inc
  • Accenture Plc
  • Tempus Labs Inc
  • Parexel International Corp
  • EPS Corp
  • Cognizant Technology Solutions Corp
  • CMIC Holdings Co Ltd
  • Veeva Systems Inc
  • Merative LP
  • Verisk Analytics Inc
  • Syneos Health Inc
  • PRA Health Sciences Inc
  • LexisNexis Risk Solutions Inc